Africa CDC Centres for Disease Control and Prevention
7
African Union
7
World Health Organisation (WHO)
5
World Health Organization WHO, Regional Office of Europe
4
Clinical Care Options
3
European Centre for Disease Prevention and Control
3
Mauder, S.
3
UN Children's Fund UNICEF
3
World Health Organization (WHO)
3
and P. Reijer
2
Dept. of Health, Republic of South Africa
2
et al.
2
Internews
2
Kamps, B.S.
2
MEDBOX
2
Mission Rabies
2
Pan American Health Organisation PAHO
2
Sallam, M.
2
WHO
2
World Health Organization WHO, et al.
2
A. García-Prado, J.P. Sarmiento, et al.
1
Action against AIDS
1
African Union, African CDC, World Health Organisation
1
AIDSinfo
1
Alliance for Health Policy and Systems Research (AHPSR) and World Health Organization
1
Ana Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
1
and J. Rüppel
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Arrieta, A.
1
Assessment Capacities Project
1
Assessment Capacities Project ACAPS
1
Australian Commission on Safety and Quality in Health Care (ACSQHC)
1
B.S. Kamps
1
Bill & Melinda Gates Foundation
1
Bishop, G.
1
British Society for Immunology
1
Brown C.M., Slavinski S., Ettestad P. et al
1
Buliva E., Elnossery S., Okwarah P. et al.
1
C. Hoffmann, et al.
1
Camp, R. and C. Hoffmann
1
Caroline Favas
1
Center for Operational Analysis and Research COAR
1
Cerda A. A., Garcia L. Y.
1
Chatanga, Peter
1
Child Health Division
1
Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al
1
CIDRAP
1
Cilliers, J.
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Corfmat, J.
1
David H. Peters, Nhan T. Tran, Taghreed Adam
1
Department: Agriculture, Foresty and Fisheries - Republic of South Africa
1
Dermot Maher
1
Durrheim, D.
1
EQUINET
1
EuroHealth Observer
1
European Asylum Support Office
1
European Centre for Disease Prevention and Control ECDC
1
European Observatory on Health Systems and Policies Eurostation
1
European specialist nurse organisation (ESN)
1
Extended Programme on Immunisation NDoH
1
Fédération Internationale des Societés de la Croix-Rouge et du Croissant Rouge
1
Florida International University
1
Food and Drug Administration (FDA)
1
G. K. Siberry
1
German Red Cross
1
Gibson, A.
1
Government of Kenya
1
Government of Malawi
1
Gromek K., Hung M., Montero N. et al
1
Health Cluster, WHO
1
Heliyon
1
Hoffmann, C.
1
Imperial College COVID-19 Response Team
1
Institute for Security Studies ISS
1
International Dairy Federation
1
International Livestock Research Institute ILRI
1
International Pharmaceutical Federation FIP
1
James W. Macharia
1
K. Lancaster
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
Kim, A.
1
Kloeck, P. et al.
1
Kompetenznetz Pulic Health Covid-19
1
LaRocque, R.
1
Lawrence Mayega, Michel M. Dione, Brian Kawuma, et al.
1
London School of Hygiene and Tropical Medicine
1
M. J. Abzug
1
María Eugenia Grillet, Fabiola Del Ventura
1
Medical Mission Institute
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health and Social Welfare, Government of Lesotho
1
Ministry of Health Kenya
1
Ministry of Health Rwanda, Biomedical Center Institute of HIV
1
Ministry of Health& Family Welfare, Goverment of India
1
Ministry of Health, Ghana, World Health Organizaiotn (WHO) and Ghana Health Service
1
Ministry of Health, Kenya
1
Ministry of Health, Kingdom of Lesotho
1
Ministry of Health, Malawi
1
Mugomeri, Eltony
1
National Association of State Public Health Veterinarians Compendium of Animal Rabies Prevention and Control Committee
1
National HIV and AIDS Secretariat
1
National Polio Emergency Operations Centre (EOC), Islamabad, Pakistan
1
National Primary Health Care Development Agency, Abuja, Nigeria
1
nature communications
1
Nature Video
1
NCTSN
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nigeria Center for Disease Control, Federal Ministry of Health, Abuja
1
NPJ
1
Nuffield Council on Bioethics
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Open WHO
1
Organisation Mondiale de la Santé, Bureau régional de l'OMS pour l'Afrique
1
Organização Mundial da Saúde. Escritório Regional para a África
1
Patrick R. Kenya, Prince-Albert Roberts, Joseph Kobba, et al.
1
PMC (US National Library of Medicine National Institutes of Health)
1
Pontifical Academy for Life
1
R Loewenson
1
R Sari Kovats et al.
1
R. Velayudhan
1
Raditladi, Tirelo et al.
1
REACH
1
Rhodes, T.
1
Robert-Koch-Institut RKI
1
Rüppel, T.
1
RüppelT.
1
S. Galwankar
1
S. Lees et al.
1
S. Nachman et al.
1
S.B. Calderwood and A.Bloom
1
S.R. Lewin and R. Sherer
1
Sachs, J., Karim, S., Aknin, L. et al.
1
Sage Working Group on Vaccine Hesitancy
1
Schmidt-Sane M.
1
Social Science in Humanitarian Action
1
Social Science in Humanitarian Action Platform
1
SSHAP
1
T. Jaenisch, K.D. Rosenberger, C. Brito, et al
1
TDR Program
1
The Johns Hopkins Center for Humanitarian Healt
1
The Lancet Commissions
1
The National Child Traumatic Stress Network
1
The ROTA Council
1
The Swedish Veterinary Association SVS
1
Tribuna del Investigador
1
Umited Nations Popuilation Fund UNFPA
1
UN High Commissioner for Refugees
1
UNICEF
1
UNICEF and UNFPA
1
UpToDate
1
USAID
1
V. Parikh
1
V. Tucci
1
Vatican COVID-19 Commission
1
Wellcome Trust
1
Wesern Cape Government, South Africa
1
World Council of Churches WCC
1
World Health Organization (WHO), Regional Office for South-East Asia
1
World Health Organization ( WHO), Regional Office for Africa
1
World Health Organization - Regional Office for South-East Asia
1
World Health Organization WHO, Regional Office for Africa
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization, Ethopian country office
1
World Health Organization, Regional Office South-East Asia
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame
...
work 2021–2030. These frameworks promote improvements in routine immunization programmes to reach all children, reduce immunity gaps and prevent outbreaks within the context of universal health care.
This interim guidance on Targeted and selective strategies in measles and rubella vaccination campaigns adds to the suite of guidance documents. It provides expanded description of methods to determine age groups for inclusion in preventive and outbreak response measles and rubella vaccination campaigns; and operational considerations that are specific to targeted and selective strategies in measles and rubella vaccination campaigns. This guidance also updates definitions for tailored, targeted and selective campaigns.The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Framework 2021–2030. These frameworks promote improvements in routine immunization programmes to reach all children, reduce immunity gaps and prevent outbreaks within the context of universal health care.
This interim guidance on Targeted and selective strategies in measles and rubella vaccination campaigns adds to the suite of guidance documents. It provides expanded description of methods to determine age groups for inclusion in preventive and outbreak response measles and rubella vaccination campaigns; and operational considerations that are specific to targeted and selective strategies in measles and rubella vaccination campaigns. This guidance also updates definitions for tailored, targeted and selective campaigns.
more
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
.e. vaccines against diphtheria, measles, pertussis, polio, tetanus, tuberculosis and yellow fever. Since then, this series has been updated and extended to include other vaccines of international importance. The main purpose of the modules is to provide national immunization managers and vaccination professionals with an overview of the scientific basis of vaccination against a range of important infectious diseases. The modules developed since 1993 continue to be vaccine-specific, reflecting the biological differences in immune responses to the individual pathogens and the differing strategies employed to create the best possible level of protection that can be provided by vaccination. The modules also serve as a record of the immunological basis for the WHO recommendations on vaccine use, published in the WHO vaccine position papers.*
more
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,
...
were accepted. By decision of the board of the Swedish Veterinary Society (SVS) these guidelines have been updated. Th e over-arching goal of SVS is to achieve a low and controlled use of antibiotics in Swedish animal production so that the fi rst-hand choices of treatment remain effi cient and that the spread of antimicrobial resistance – among animals and herds as well as in the food chain – is kept at a minimum. Keeping antimicrobial resistance in animals low is important also for human health, since we are all part of the same ecosystem. Th e authors of these guidelines hope that they may be useful for veteri-narians in clinical practice when deciding on treatments for common diseases and ailments caused by bacteria. Sometimes the decision may even be to refrain from use of antibiotics and chose other ways of improving herd health.
more
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b
...
e updated as it becomes available.
more
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m
...
easures is likely to be an important determinant of their success. Indeed, as these measures were relaxed, subsequent waves of disease have been observed in many countries including South Africa, Kenya, Tunisia, Morocco, Sudan and the Democratic Republic of Congo (DRC) where such waves have severely impacted the health system by straining the supply of oxygen and ICU beds and inflicting a heavy toll on healthcare workers, often necessitating the re-imposition of control measures.
more
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herdimmunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is importa
...
nt
to identify sources of variation so that policies can be tailored to different population groups. In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and
laggers in six big cities of Latin America. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, perceived risk of getting sick, and being a student
increase the odds to get vaccinated. We also identify potential laggers as women and populations between 20 and 35 years old who are not students. We discuss specific strategies to promote vaccination among
these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be
vaccinated vary significantly by location and in relation to individual-level factors.
more
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health
...
interventions during crises.
The WHO Strategic Advisory Group of Experts (SAGE) on Immunization carried out a comprehensive review of evidence on vaccination decision-making processes and considerations in humanitarian emergencies.
more
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc
...
e, and the role of behavior change.
more
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herdimmunity. Following
...
the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
more
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
Switzerland, from 5 to 7 October 2009. This allowed the Consultation to benefit from the participation of the national coordinators and advisers of the BMGF-funded projects in the Philippines, South Africa (KwaZulu-Natal) and the United Republic of Tanzania
more
Herdimmunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis
...
of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how five features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.
more